MoneyWorks4Me

Bliss GVS Pharma informs about disclosure

12 Nov 2020 Evaluate

Bliss GVS Pharma has informed that the exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on November 11, 2020 for Gautam Rasiklal Ashra.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1857.45
Dr. Reddys Labs. 1150.80
Cipla 1355.70
Lupin 2052.35
Zydus Lifesciences 1107.95
View more..